AMENDMENT NO. 1 TO CALLABLE SECURED CONVERTIBLE NOTESGrant Life Sciences, Inc. • July 1st, 2005 • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 1 TO CALLABLE SECURED CONVERTIBLE NOTES (the “Amendment”) is made as of this 1st day of July, 2005, by and between Grant Life Sciences, Inc., a Nevada corporation (the “Company”), and the holders of Callable Secured Convertible Notes issued by the Company on June 14, 2005 set forth on the signature page hereof (each, a “Holder” and, collectively, the “Holders”). Capitalized terms used herein and not defined shall have the meanings given to them in the Notes (as defined below).
